SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Quince Therapeutics, Inc. (QNCX)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
2.5 / 10
Letters
1
Latest Activity
Feb. 12, 2026
Version
v1

Score Breakdown

Letter Count
1.0
Sentiment / Tone
0.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
1.0
Notable 8-K Count
1

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Aug. 1, 2025 CORRESP Neutral/Informational Moderate Quince Therapeutics, Inc. has submitted a request to the U.S. Securities and Exchange Commission to expedite the effectiveness of their Registration Statement on Form S-3, which i… Read Filing EDGAR
Aug. 1, 2025 UPLOAD Neutral/Informational Low The SEC has issued a correspondence to Quince Therapeutics, Inc. regarding their Registration Statement on Form S-3 filed on July 25, 2025. The SEC has stated that they will not r… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.